ArticleFrontiers in pharmacology2024

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma.

Run-Jie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.